"Das Knappschaftskrankenhaus Bochum wurde 1909 als Gemeindekrankenhaus gegründet und ist seit 1977 Universitätsklinik der Ruhr-Universität Bochum. Heute verfügt das Universitätsklinikum über 479 Betten und neun Fachabteilungen. Jedes Jahr werden 22.000 stationäre sowie ca. 50.000 ambulante Patienten behandelt. Den hohen Standard der Patientenversorgung stellen 1600 hochqualifizierte und motivierte Mitarbeiter sicher. Durch die moderne apparative und technische Ausstattung sind innovative Diagnose- und Therapieverfahren etabliert. (Stand: 2019)"

During the past decade, Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic" #1 collaborator was "German Cancer Aid" with 1 trials as a collaborator, "German Cancer Research Center" with 1 trials as a collaborator, "National Center for Tumor Diseases, Heidelberg" with 1 trials as a collaborator, "Ruhr University of Bochum" with 1 trials as a collaborator and "Universitätsmedizin Mannheim" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic" are "Glioblastoma, Adult" (1 trials) and "Oligodendroglioma" (1 trials). Many other conditions were trialed in "Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic" in a lesser frequency.

Most popular intervention types in "Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "APG101" (1 trials), "Alectinib" (1 trials), "Atezolizumab" (1 trials), "CETEG" (1 trials) and "Idasanutlin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".